Where to buy Pomalidomide

Pomalidomide, an oral capsule that may be useful for people with multiple myeloma who have failed other treatments, is part of a class of drugs called immunomodulators. Pomalidomide helps the bone marrow produce normal blood cells and also enhances the ability of immune cells to kill abnormal cells in the bone marrow. Patients with advanced multiple myeloma have disease that worsens after multiple lines of therapy, with few treatment options and poor prognosis. The median survival of these patients was 9 months. The U.S. Food and Drug Administration (FDA) granted accelerated approval to pomalidomide for the treatment of patients with multiple myeloma who have received at least two prior therapies, including lenalidomide (Revlimid) and bortezomib (Velcade), and whose disease has progressed within 60 days of completing the last therapy.

Pomalidomide, independently developed in China, has been launched in the country and is now covered by medical insurance. The price of domestically produced pomalidomide per box may be around RMB 4,000. This drug may be sold in domestic pharmacies or hospitals. The price of each box of the Turkish version listed overseas may be around 15,000 yuan (the price may fluctuate due to exchange rates), which is relatively expensive. There are also cheaper generic drugs produced in other countries overseas. The price of each box produced by a Lao pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to the exchange rate). The ingredients of foreign generic drugs, domestically produced drugs and foreign original drugs are basically the same. For more drug information and specific prices, please consult a medical consultant. Purchase overseas drugs must be purchased through formal channels.